Circular RNA SMARCA5 inhibits gastric cancer progression through targeting the miR-346/ FBXL2 axis

Quanying Li1, Hongna Tang1, Fangfang Hu1

  • 1Department of General Surgery, Huaihe Hospital of Henan University No. 8 of Baobei Road Kaifeng 475000 China hhyychangjiangqin@163.com +86-371-23906957 +86-371-23906957.

RSC Advances
|May 6, 2022
PubMed

Insights

Circular RNA SMARCA5 (circSMARCA5) acts as a tumor suppressor in gastric cancer. It inhibits proliferation, migration, and invasion by regulating the microRNA-346/FBXL2 pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNA SMARCA5 (circSMARCA5) is implicated in various cancers.
  • Its specific role in gastric cancer remains uninvestigated.

Purpose of the Study:

  • To elucidate the function and underlying mechanism of circSMARCA5 in gastric cancer progression.

Main Methods:

  • Assessed circSMARCA5 expression in gastric cancer tissues and cell lines.
  • Performed in vitro experiments including cell proliferation, migration, and invasion assays.
  • Utilized luciferase reporter assays to identify interactions between circSMARCA5, miR-346, and FBXL2.

Main Results:

  • circSMARCA5 expression was significantly downregulated in gastric cancer.
  • Overexpression of circSMARCA5 suppressed gastric cancer cell proliferation, migration, and invasion.
  • circSMARCA5 functions as a molecular sponge for miR-346, thereby regulating FBXL2 expression.

Conclusions:

  • circSMARCA5 exhibits tumor suppressor activity in gastric cancer.
  • The circSMARCA5/miR-346/FBXL2 axis is a critical pathway in gastric cancer development.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.3K